BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11359369)

  • 1. Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?
    Layfield R
    Med Hypotheses; 2001 Mar; 56(3):395-9. PubMed ID: 11359369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 26S proteasome: ubiquitin-mediated proteolysis in the tunnel.
    Kierszenbaum AL
    Mol Reprod Dev; 2000 Oct; 57(2):109-10. PubMed ID: 10984410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein degradation and protection against misfolded or damaged proteins.
    Goldberg AL
    Nature; 2003 Dec; 426(6968):895-9. PubMed ID: 14685250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome.
    Lam YA; Xu W; DeMartino GN; Cohen RE
    Nature; 1997 Feb; 385(6618):737-40. PubMed ID: 9034192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of ornithine decarboxylase by the 26S proteasome.
    Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
    Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant development: regulation by protein degradation.
    Hellmann H; Estelle M
    Science; 2002 Aug; 297(5582):793-7. PubMed ID: 12161644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
    Feiková S; Wolff L; Bies J
    Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes.
    Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM
    Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydrophobic effect contributes to polyubiquitin chain recognition.
    Beal RE; Toscano-Cantaffa D; Young P; Rechsteiner M; Pickart CM
    Biochemistry; 1998 Mar; 37(9):2925-34. PubMed ID: 9485444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.
    Glickman MH; Ciechanover A
    Physiol Rev; 2002 Apr; 82(2):373-428. PubMed ID: 11917093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cryptic protease couples deubiquitination and degradation by the proteasome.
    Yao T; Cohen RE
    Nature; 2002 Sep; 419(6905):403-7. PubMed ID: 12353037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome.
    Bonvini P; Nguyen P; Trepel J; Neckers LM
    Oncogene; 1998 Mar; 16(9):1131-9. PubMed ID: 9528855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the proteasome in ethanol-induced liver pathology.
    Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Nedd8-associated polypeptides: a model for deciphering the pathway for ubiquitin-like modifications.
    Norman JA; Shiekhattar R
    Biochemistry; 2006 Mar; 45(9):3014-9. PubMed ID: 16503656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of COP9 signalosome and 26S proteasome interaction.
    Huang X; Hetfeld BK; Seifert U; Kähne T; Kloetzel PM; Naumann M; Bech-Otschir D; Dubiel W
    FEBS J; 2005 Aug; 272(15):3909-17. PubMed ID: 16045761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.
    Lam YA; Pickart CM; Alban A; Landon M; Jamieson C; Ramage R; Mayer RJ; Layfield R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9902-6. PubMed ID: 10944193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
    Amir R; Ciechanover A; Cohen S
    Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system.
    Verma R; Oania R; Graumann J; Deshaies RJ
    Cell; 2004 Jul; 118(1):99-110. PubMed ID: 15242647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.
    Wang J; Maldonado MA
    Cell Mol Immunol; 2006 Aug; 3(4):255-61. PubMed ID: 16978533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.